ArticlemAbs
A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation.
Alessandro Mega et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
cites it
ArticlemAbs
Alessandro Mega et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.